Novartis Ag (NVS) Gross Profit (2009 - 2026)

Novartis Ag has disclosed Gross Profit across 18 years of filings, most recently posting $11.2 billion for Q2 2026.

• In Q2 2026, Gross Profit fell 2.37% year-over-year to $11.2 billion; the TTM figure through Jun 2026 stood at $54.0 billion (down 10.7% YoY), while the FY2025 annual figure was $43.0 billion, up 10.49% from the prior year.
• Gross Profit came in at $11.2 billion for Q2 2026 at Novartis Ag, up from $10.1 billion in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $28.7 billion in Q4 2024 to a low of $7.9 billion in Q3 2022.
• Average Gross Profit over 5 years is $13.0 billion, with a median of $10.0 billion recorded in 2024.
• Year-over-year, Gross Profit surged 32.82% in 2022 and fell 23.57% in 2025.
• Over 5 years, Gross Profit stood at $24.0 billion in 2022, then climbed by 6.18% to $25.4 billion in 2023, then climbed by 12.69% to $28.7 billion in 2024, then retreated by 23.57% to $21.9 billion in 2025, then sank by 48.69% to $11.2 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $11.2 billion in Q2 2026, $10.1 billion in Q1 2026, and $21.9 billion in Q4 2025.